184 related articles for article (PubMed ID: 37187268)
21. The Keap1/Nrf2-ARE Pathway as a Pharmacological Target for Chalcones.
de Freitas Silva M; Pruccoli L; Morroni F; Sita G; Seghetti F; Viegas C; Tarozzi A
Molecules; 2018 Jul; 23(7):. PubMed ID: 30037040
[TBL] [Abstract][Full Text] [Related]
22. Directly interact with Keap1 and LPS is involved in the anti-inflammatory mechanisms of (-)-epicatechin-3-gallate in LPS-induced macrophages and endotoxemia.
Chiou YS; Huang Q; Ho CT; Wang YJ; Pan MH
Free Radic Biol Med; 2016 May; 94():1-16. PubMed ID: 26878775
[TBL] [Abstract][Full Text] [Related]
23. An insight into role of amino acids as antioxidants via NRF2 activation.
Egbujor MC; Olaniyan OT; Emeruwa CN; Saha S; Saso L; Tucci P
Amino Acids; 2024 Mar; 56(1):23. PubMed ID: 38506925
[TBL] [Abstract][Full Text] [Related]
24. Discovery of the negative regulator of Nrf2, Keap1: a historical overview.
Itoh K; Mimura J; Yamamoto M
Antioxid Redox Signal; 2010 Dec; 13(11):1665-78. PubMed ID: 20446768
[TBL] [Abstract][Full Text] [Related]
25. Possible activation of NRF2 by Vitamin E/Curcumin against altered thyroid hormone induced oxidative stress via NFĸB/AKT/mTOR/KEAP1 signalling in rat heart.
Mishra P; Paital B; Jena S; Swain SS; Kumar S; Yadav MK; Chainy GBN; Samanta L
Sci Rep; 2019 May; 9(1):7408. PubMed ID: 31092832
[TBL] [Abstract][Full Text] [Related]
26. The principal molecular mechanisms behind the activation of Keap1/Nrf2/ARE pathway leading to neuroprotective action in Parkinson's disease.
Chakkittukandiyil A; Sajini DV; Karuppaiah A; Selvaraj D
Neurochem Int; 2022 Jun; 156():105325. PubMed ID: 35278519
[TBL] [Abstract][Full Text] [Related]
27. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
29. Toxico-pharmacological perspective of the Nrf2-Keap1 defense system against oxidative stress in kidney diseases.
Saito H
Biochem Pharmacol; 2013 Apr; 85(7):865-72. PubMed ID: 23333765
[TBL] [Abstract][Full Text] [Related]
30. Nuclear factor erythroid 2-related factor 2 (Nrf2) as a potential therapeutic target for vitiligo.
Lin X; Meng X; Song Z; Lin J
Arch Biochem Biophys; 2020 Dec; 696():108670. PubMed ID: 33186606
[TBL] [Abstract][Full Text] [Related]
31. An Overview of the Nrf2/ARE Pathway and Its Role in Neurodegenerative Diseases.
Zgorzynska E; Dziedzic B; Walczewska A
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502501
[TBL] [Abstract][Full Text] [Related]
32. The Regulation of NRF2 by Nutrient-Responsive Signaling and Its Role in Anabolic Cancer Metabolism.
Lee SB; Sellers BN; DeNicola GM
Antioxid Redox Signal; 2018 Dec; 29(17):1774-1791. PubMed ID: 28899208
[TBL] [Abstract][Full Text] [Related]
33. Recent Advances in
Rampin A; Carrabba M; Mutoli M; Eman CL; Testa G; Madeddu P; Spinetti G
Antioxid Redox Signal; 2022 Apr; 36(10-12):707-728. PubMed ID: 35044251
[No Abstract] [Full Text] [Related]
34. MDA-7/IL-24 inhibits Nrf2-mediated antioxidant response through activation of p38 pathway and inhibition of ERK pathway involved in cancer cell apoptosis.
Tian H; Zhang D; Gao Z; Li H; Zhang B; Zhang Q; Li L; Cheng Q; Pei D; Zheng J
Cancer Gene Ther; 2014 Oct; 21(10):416-26. PubMed ID: 25236495
[TBL] [Abstract][Full Text] [Related]
35. KPNA6 (Importin {alpha}7)-mediated nuclear import of Keap1 represses the Nrf2-dependent antioxidant response.
Sun Z; Wu T; Zhao F; Lau A; Birch CM; Zhang DD
Mol Cell Biol; 2011 May; 31(9):1800-11. PubMed ID: 21383067
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-200a improves diabetic endothelial dysfunction by targeting KEAP1/NRF2.
Jiang Z; Wu J; Ma F; Jiang J; Xu L; Du L; Huang W; Wang Z; Jia Y; Lu L; Wu H
J Endocrinol; 2020 Apr; 245(1):129-140. PubMed ID: 32031966
[TBL] [Abstract][Full Text] [Related]
37. Gallic acid, a natural polyphenol, protects against tert-butyl hydroperoxide- induced hepatotoxicity by activating ERK-Nrf2-Keap1-mediated antioxidative response.
Feng RB; Wang Y; He C; Yang Y; Wan JB
Food Chem Toxicol; 2018 Sep; 119():479-488. PubMed ID: 29066411
[TBL] [Abstract][Full Text] [Related]
38. Nrf2/Keap1/ARE signaling: Towards specific regulation.
Ulasov AV; Rosenkranz AA; Georgiev GP; Sobolev AS
Life Sci; 2022 Feb; 291():120111. PubMed ID: 34732330
[TBL] [Abstract][Full Text] [Related]
39. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
[TBL] [Abstract][Full Text] [Related]
40. The nuclear factor erythroid 2-related factor 2/p53 axis in breast cancer.
Xia L; Ma W; Afrashteh A; Sajadi MA; Fakheri H; Valilo M
Biochem Med (Zagreb); 2023 Oct; 33(3):030504. PubMed ID: 37841775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
